EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Key Sessions

Lizabeth Leveille

What's the next big thing on pharma's wish list?


Eddy Anglade

Cell and Gene Therapies: From discovery to commercialization

The Astellas Institute of Regenerative Medicine

7:30am 7:30am (0 mins)


Registration, exhibition and breakfast

Grand Ballroom Foyer

8:00am 4:30pm (510 mins)

Pitch and Partner

One-to-one meetings

Grand Ballroom, Republic B

9:30am 12:15pm (165 mins)

Pitch and Partner

Biotech presentations

Independence East, Republic A

8:30am 9:00am (30 mins)

Translational Impact Forum

Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development

From Bedside to Bench and Back Again: Using Clinical Data to Develop Translatable Models for Drug Discovery

Back Bay

8:30 am – Welcome and live broadcast start

Speaker: James C. Foster

  • Speaker James C. Foster - Chairman, President and CEO, Charles River

9:00am 12:20pm (200 mins)

Translational Impact Forum


Back Bay

9:00 am – Application of genomic data to immuno-oncology

Speaker: Francesco Marincola, MD, FACS

10:00 am – Break

10:20 am – Translating animal studies to successful human therapies

Speaker: James M. Wilson, MD, PhD

11:20 am – Genetic screens to study cancer biology

Speaker: David M. Sabatini, MD, PhD

  • Speaker Francesco Marincola, MD, FACS - Distinguished Research Fellow in Immuno-Oncology, AbbVie
  • Speaker David Sabatini, MD, PhD - Member, Whitehead Institute; Professor of Biology, MIT; Investigator, Howard Hughes Medical Institute
  • Speaker James Wilson, MD, PhD - Professor, Internal Medicine and Pathology and Laboratory Medicine; Director, Gene Therapy Program, Perelman School of Medicine, University of Pennsylvania

10:00am 10:15am (15 mins)

Startup Program


Independence West

  • Speaker Donna LaVoie - President and CEO, LaVoieHealthScience

10:15am 11:00am (45 mins)

Startup Program

EBD Academy Buzz Session: Taking a look at the softer side of negotiation

Independence West

A short buzz training session delivered by EBD Academy 


This short and concise session will examine the “softer side of negotiation” providing you with deeper insights into the human mind during negotiations, better assisting you in future deals. Most professionals focus on the process, tactics and the importance of uncovering important insights into the other party's needs. This brief presentation will provide examples showing that things are not always as they appear and the human mind does not always think rationally and logically. 

Session breakdown 

The following areas will be discussed during the session  

  • Confirmation bias 
  • Overconfidence 
  • Competitor's neglect  
  • Risk and loss aversion  
  • Fairness and anchoring  
  • The importance of influence and persuasion skills   

What is a Buzz session? 

Delivered by EBD Academy and developed in partnership with EBD Group, buzz sessions will provide attendees with take-away skills and knowledge that will benefit them while at the event and in their professional careers. All buzz sessions are designed to be concise, informative and engaging which creates a learning environment that is exciting to be a part of.  

Benefits of attending a Buzz session 

  • Gain practical skills that can be implemented immediately at the EBD event  
  • High intensity sessions designed to improve your skillset  
  • Interactive 
  • Learn from the expert and others attending the session   
  • Concise and informative
  • Trainer Anjan Aralihalli - Chief Business Officer, GLyPharma Therapeutic

11:00am 11:15am (15 mins)

Startup Program

How to tell your story

Independence West

  • Speaker Hal Mackins - Senior Partner, Torch Communications

11:15am 11:30am (15 mins)

Startup Program

Establishing and protecting your IP

Independence West

  • Speaker Cullen Taylor - Partner, Hogan Lovells

11:30am 11:45am (15 mins)

Startup Program

The partnership before the partnership: Working with a CRO to get the most out of your first trial

Independence West

  • Speaker Peter Sausen - VP, Global Head Early Phase Development Solutions, Covance Laboratories

11:45am 12:00pm (15 mins)

Startup Program

Working with nontraditional partners

Independence West

  • Speaker Nina Kandilian - Operations Manager, PULSE@MassChallenge

12:00pm 12:15pm (15 mins)

Startup Program

Valuing your startup: How does the valuation process work?

Independence West

  • Speaker Rafaèle Tordjman - Special Advisor, Sofinnova Partners

12:15pm 1:15pm (60 mins)



Constitution, Grand Ballroom Foyer

1:30pm 4:50pm (200 mins)

Translational Impact Forum

TRACK ONE: Improving translatability of animal models in drug discovery

Back Bay B

1:30 pm –A diet-induced animal model of nonalcoholic fatty liver disease

Speaker: Arun Sanyal, MD

2:30 pm – Intrinsic aerobic capacity and susceptibility for metabolic dysfunction

Speaker: John P. Thyfault, PhD

3:30 pm – Break

3:50 pm –Diet preferences in large animal models of cardiovascular disease: Does it matter?

Speaker: Anthony Comuzzie, PhD, FTOS

  • Speaker Anthony Comuzzie, PhD, FTOS - Executive Director, The Obesity Society
  • Speaker John P. Thyfault, PhD - Associate Professor of Physiology, University of Kansas
  • Speaker Arun Sanyal, MD - Professor, Department of Internal Medicine Division of Gastroenterology, Virginia Commonwealth University

1:30pm 4:50pm (200 mins)

Translational Impact Forum

TRACK TWO:  Non-traditional animal models for drug discovery

Back Bay A

1:30 pm – Small molecule discovery for regenerative medicine: The essential role of non-traditional animal models

Speaker: Kevin Strange, PhD

2:30 pm – Bugs as drugs

Speaker: Kip West, PhD

3:30 pm – Break

3:50 pm – Rapid 3D bioprinting of blood vessel network and microphysiological systems

Speaker: Shaochen Chen, PhD

  • Speaker Shaochen Chen, PhD - Professor, University of California, San Diego
  • Speaker Kip West, PhD - Director, Pharmacology, Synlogic
  • Speaker Kevin Strange, PhD - President and CEO, MDI Biological Laboratory; Co-Founder and CEO, Novo Biosciences, Inc.

1:30pm 4:50pm (200 mins)

Translational Impact Forum

TRACK THREE:  How reverse translation has influenced animal model creation

Back Bay C

1:30 pm – Mouse models for atherosclerosis

Speaker: Alan Daugherty, PhD, DSc, FAHA

2:30 pm – Recapitulating human patient mutations in mouse oncology models

Speaker: Dejan Juric, MD

3:30 pm – Break 

3:50 pm – Rat models of susceptibility to complex diseases: A solution to Eroom's law

Speaker: Steven Britton, PhD

  • Speaker Steven Britton, PhD - Professor of Anesthesiology, Professor of Molecular and Integrative Physiology, University of Michigan School of Medicine
  • Speaker Alan Daugherty, PhD, DSc, FAHA - Associate VP for Research; Senior Associated Dean for Research, College of Medicine Chair, Department of Physiology, University of Kentucky College of Medicine
  • Speaker Dejan Juric, MD - Director of Translational Research, Termeer Center for Targeted Therapies, Massachusetts General Hospital

1:30pm 2:15pm (45 mins)

Strategy and Business

Beyond IO: A future free from silos

Independence West

  • Moderator Debbi Amanti Belanger - Principal, ClearView Healthcare Partners
  • Panelist Gabriela Apiou - Director, Translational Research Training and Development, Mass General Hospital Research Institute
  • Panelist Philip Gotwals - Head, Search and Evaluation Strategic Alliances, Novartis Institutes for BioMedical Research, Inc.
  • Panelist Garry Menzel - CEO, TCR2 Therapeutics
  • Panelist Patrick Tricoli - CEO, Nanobiotix USA

2:30pm 3:15pm (45 mins)

Strategy and Business

What's the next big thing on pharma's wish list?

Independence West

  • Panelist Lizabeth Leveille - Associate VP and Head, Boston Innovation Hub, BD&L, Merck
  • Panelist Salim Mujais - Senior VP, Global Therapeutic Head Immunology, Transplant, Infectious Disease, CNS and Pain, Astellas
  • Panelist Chandra Ramanathan - Head, East Coast Innovation Center, Bayer
  • Panelist Aaron Schwartz - Director, R&D Innovation Sourcing, Novo Nordisk Inc.
  • Moderator Ed Silverman - Senior Writer and Pharmalot Columnist, STAT News

3:30pm 4:15pm (45 mins)

Strategy and Business

Cell and Gene Therapies: From discovery to commercialization

Independence West

  • Panelist Eddy Anglade - CMO, Global Therapy Area Head, The Astellas Institute of Regenerative Medicine
  • Panelist Vivian Choi - Associate Director, Head of Gene Therapy Research, Discovery Therapeutics, Shire
  • Panelist Michael Cooke - CSO, Magenta Therapeutics
  • Panelist Peter G. Nell - VP, Head Strategy and Business Development, Casebia Therapeutics
  • Moderator Patricia Reilly - VP, Intelligence Alliances and Product Unification, Pharma Intelligence, Informa

4:30pm 5:30pm (60 mins)


Closing reception